Visceral Adiposity Index
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To individuate a novel sex-specific index, based on waist circumference, BMI, triglycerides, and HDL cholesterol, indirectly expressing visceral fat function. RESEARCH DESIGN AND METHODS: Visceral adiposity index (VAI) was first modeled on 315 nonobese healthy subjects. Using two multiple logistic regression models, VAI was retrospectively validated in 1,498 primary care patients in comparison to classical cardio- and cerebrovascular risk factors. RESULTS: All components of metabolic syndrome increased significantly across VAI quintiles. VAI was independently associated with both cardiovascular (odd ratio [OR] 2.45; 95% CI 1.52–3.95; P < 0.001) and cerebrovascular (1.63; 1.06–2.50; P = 0.025) events. VAI also showed significant inverse correlation with insulin sensitivity during euglycemic-hyperinsulinemic clamp in a subgroup of patients (Rs = −0.721; P < 0.001). By contrast, no correlations were found for waist circumference and BMI. CONCLUSIONS: Our study suggests VAI is a valuable indicator of “visceral adipose function” and insulin sensitivity, and its increase is strongly associated with cardiometabolic risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“increased fat mass is associated with elevated adipocytokine and proinflammatory cytokines, insulin resistance, increased risk of developing adverse outcomes of diabetes, hypertriglyceridemia, hypercholesterolemia, hypertension, atherosclerosis, and a higher mortality rate [10].”
From Trend of various adiposity indices in women with and without history of gestational diabetes: a population-based cohort study (2019) · cites this paper as [10]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pouliot, M.-C., Després, J.-P., Lemieux, S., Moorjani, S., Bouchard, C., Tremblay, A., Nadeau, A., & Lupien, P. J. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90676-9 · Cited by 2,085
Ohlson, L. O., Larsson, B., Svärdsudd, K., Welin, L., Eriksson, H., Wilhelmsen, L., Björntorp, P., & Tibblin, G. (1985) · Diabetes · doi:10.2337/diab.34.10.1055 · Cited by 1,020
Unger, R. H. (2003) · Endocrinology · doi:10.1210/en.2003-0870 · Cited by 677 · cited 1×
“Indeed, this condition characterized by visceral obesity and “high-triglyceride/low–HDL cholesterol dyslipidemia” has been associated with physiological age-linked leptin resistance, muscle, and liver insulin resistance, lipotoxic cardiomyopathy, and generalized endothelial dysfunction (15).”
BackgroundIs visceral obesity the cause of the metabolic syndrome?
Després, J. (2006) · Annals of Medicine · doi:10.1080/07853890500383895 · Cited by 651
Age-related inflammatory cytokines and disease
Brüünsgaard, H., & Pedersen, B. K. (2003) · Immunology and Allergy Clinics of North America · doi:10.1016/s0889-8561(02)00056-5 · Cited by 608 · cited 1×
“V isceral obesity (1) is associated with increased adipocytokine production, proinflammatory activity (2), deterioration of insulin sensitivity (3), increased risk of developing diabetes, “high-triglyceride/low–HDL cholesterol dyslipidemia,” hypertension, atherosclerosis, and higher mortality rate (4–7).”
BackgroundSubdivisions of subcutaneous abdominal adipose tissue and insulin resistance
Kelley, D. E., Thaete, F. L., Troost, F., Huwe, T., & Goodpaster, B. H. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.278.5.e941 · Cited by 538
Body fat distribution, insulin resistance, and metabolic diseases
Björntorp, P. (1997) · Nutrition · doi:10.1016/s0899-9007(97)00191-3 · Cited by 470
High Visceral and Low Abdominal Subcutaneous Fat Stores in the Obese Adolescent
Taksali, S. E., Caprio, S., Dziura, J., Dufour, S., Calí, A. M. G., Goodman, T. R., Papademetris, X., Burgert, T. S., Pierpont, B. M., Savoye, M., et al. (2008) · Diabetes · doi:10.2337/db07-0932 · Cited by 353
Rader, D. J. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.01.003 · Cited by 346
Visceral Fat in Hypertension: Influence on Insulin Resistance and β-Cell Function
Sironi, A. M., Gastaldelli, A., Mari, A., Ciociaro, D., Postano, V., Buzzigoli, E., Ghione, S., Turchi, S., Lombardi, M., & Ferrannini, E. (2004) · Hypertension · doi:10.1161/01.hyp.0000137982.10191.0a · Cited by 268
Research works printed but not linked: 1
- De Fronzo, 1979, The glucose clamp technique: a method for the quantification of beta cell sensitivity to glucose and of tissue sensitivity to insulin, Am J Physiol, 237, 214
Cited by
Items 501–600 of 1,005
Fat mass and obesity-associated gene expression and disease severity in type 2 diabetes mellitus
Gayed, E. M. A. E., Zewain, S. K., Ragheb, A., & El-Naidany, S. S. (2021) · Steroids · doi:10.1016/j.steroids.2021.108897 · Cited by 25
Neeland, I. J., McGuire, D. K., Eliasson, B., Ridderstråle, M., Zeller, C., Woerle, H. J., Broedl, U. C., & Johansen, O. E. (2015) · Diabetes Therapy · doi:10.1007/s13300-015-0146-7 · Cited by 25
Ruiz‐García, A., Serrano-Cumplido, A., Escobar, C., Arranz-Martínez, E., & Pallarés‐Carratalá, V. (2024) · Nutrients · doi:10.3390/nu16223948 · Cited by 24
“…ratio, based on WC and hip circumference; the Conicity Index [9], based on WC, BMI, and height; the ARI 10], based on BMI and ABSI; the BRI [11], based on WC and height; the BAI [12], based on hip circumference and height; and the VAI [13], based on WC, BMI, HDL-C levels, and triglyceride levels.”
Cuschieri, S., Vassallo, J., Calleja, N., Pace, N. P., & Mamo, J. A. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.03.009 · Cited by 24
Zierfuss, B., Höbaus, C., Herz, C. T., Pesau, G., Koppensteiner, R., & Schernthaner, G.-H. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.03.019 · Cited by 24
Metabolically healthy obesity: is there a link with polyunsaturated fatty acid intake and status?
Arsić, A., Takić, M. M., Kojadinović, M., Petrović, S., Paunović, M., Vučić, V., & Ristić-Medić, D. (2020) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2020-0317 · Cited by 24
Xie, Y., Zhang, Y., Qin, P., Ping, Z., Wang, C., Peng, X., Chen, H., Zhao, D., Xu, S., Wang, L., et al. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.10.020 · Cited by 24
Lee, W.-C., Wu, P.-Y., Huang, J., Tsai, Y., Chiu, Y., Chen, S., Chang, J., & Chen, H. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12060972 · Cited by 24
Guo, L., Wang, Y., Wang, J.-H., Zhao, H., Yu, Y., Wang, G.-D., Dai, K., Yan, Y., Yang, Y., & Lv, J. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i27.3455 · Cited by 24
Jafari, A., Najafipour, H., Shadkam, M., & Aminizadeh, S. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01932-x · Cited by 24
Pang, H., Yin, Y., Xue, J., Chen, X., Pang, J., Zhang, J., & Sun, Y. (2023) · World Journal of Urology · doi:10.1007/s00345-023-04667-7 · Cited by 24
Cândido, F. G., da Silva, A., Zanirate, G. A., Oliveira, N. M. C. E., & Hermsdorff, H. H. M. (2024) · Inflammation · doi:10.1007/s10753-024-02063-w · Cited by 24
Tao, X., Xu, X. M., Xu, Y., Yang, Q., Yang, T., Zhou, X., Xue, H., Ren, X., & Luo, F. (2024) · BMC Public Health · doi:10.1186/s12889-024-19810-1 · Cited by 24
Huang, J., Huang, Y., Lu, C.-H., Chuang, Y., Chien, H., Lin, C.-I., Chao, M., Chuang, H., Ho, C.-K., Wang, C.-L., et al. (2024) · Life · doi:10.3390/life14111399 · Cited by 24
“The formulas used to calculate VAI and TyG index were listed as follows [19,24]: VAI for men = WC (cm)/(39.68 + (1.88 × BMI)) × (TG (mmol/L)/1.03) × (1.31/HDL cholesterol (mmol/L)); VAI for women = WC (cm)/(36.58 + (1.89 × BMI)) × (TG (mmol/L)/0.81) × (1.52/HDL cholesterol (mmol/L)); TyG Index =…”
InfluentialPrediction of MASLD using different screening indexes in Chinese type 2 diabetes mellitus
Hu, M., Yang, J., Gao, B., Wu, Z., Wu, Y., Hu, D., Shen, Q. “., & Chen, L. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01571-x · Cited by 24
Zou, Zhao, Y., Zhao, Z., Zhu, S., Liu, X., Zhou, C., Xu, X., Shao, X., Liang, Y., Duan, C., et al. (2016) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s96340 · Cited by 24
Visceral adiposity index and prognosis among patients with ischemic heart failure
Vogel, P., Stein, A. T., & Marcadenti, A. (2016) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2015.01452111 · Cited by 24
Hormoznejad, R., Shahi, M. M., Rahim, F., Helli, B., Alavinejad, P., & Sharhani, A. (2020) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2020.1746957 · Cited by 24
Ożegowska, K., Bogacz, A., Bartkowiak-Wieczorek, J., Seremak‐Mrozikiewicz, A., & Pawelczyk, L. A. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5910 · Cited by 24
High School Reform: The Need for Engineering.
Sizer, T. R. (1983) · Phi Delta Kappan · Cited by 24
Boone, S. C., van Smeden, M., Rosendaal, F. R., le Cessie, S., Groenwold, R. H. H., Jukema, J. W., van Dijk, K. W., Lamb, H. J., Greenland, P., Neeland, I. J., et al. (2022) · American Journal of Epidemiology · doi:10.1093/aje/kwab298 · Cited by 23
Radetti, G., Grugni, G., Lupi, F., Fanolla, A., Caroli, D., Bondesan, A., & Sartório, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154488 · Cited by 23
Hulkoti, V. S., Acharya, S., Shukla, S., Kumar, S., Kabra, R., Dubey, A., Lahane, V., & Giri, A. (2022) · Cureus · doi:10.7759/cureus.31279 · Cited by 23
Amirkhizi, F., Khademi, Z., Shahraki, S. H., & Rahimlou, M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1080138 · Cited by 23
Seo, M.-W., Cho, W., & Kim, J. Y. (2023) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2023.05.001 · Cited by 23
Mintoff, D., Agius, R., Fava, S., & Pace, N. P. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144847 · Cited by 23
“Visceral adiposity index (VAI) and atherogenic index of plasma (AIP) were calculated from clinical and biochemical parameters [27,28].”
MethodNiyazi, A., Yasrebi, S. M. A., Yazdanian, M., & Rahimi, G. R. M. (2024) · Biological Research For Nursing · doi:10.1177/10998004241239330 · Cited by 23
“LAP represents the accumulation of excessive lipids in the body, while VAI serves as an indicator of the functionality of visceral adipose tissue (Amato et al., 2010; Xia et al., 2012).”
BackgroundMethodSodero, G., Rigante, D., Pane, L. C., Sessa, L., Quarta, L., Candelli, M., & Cipolla, C. (2024) · Diseases · doi:10.3390/diseases12060119 · Cited by 23
“- Visceral adiposity index (VAI) [17], calculated as reported in Figure 1; it describes how all determinants of the metabolic syndrome increase their absolute value in the presence of a higher VAI (>2.5) [18].”
MethodInfluentialRana, S., & Bhatti, A. A. (2019) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-019-00765-x · Cited by 23
Zheng, S., Tong, M., Dong, L., Du, C., Zheng, X. M., Wang, L., Huang, P., Liu, W., Lin, M., & Liu, C. (2020) · Endocrine Connections · doi:10.1530/ec-19-0559 · Cited by 23
Rodríguez-Mortera, R., Caccavello, R. J., Garay‐Sevilla, M. E., & Gugliucci, A. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.05.014 · Cited by 24
Keskinler, M. V., Mutlu, H. H., Şirin, A., ŞENATEŞ, B. E., Çolak, Y., Tuncer, İ., & Oğuz, A. (2020) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2020.0054 · Cited by 23
Díez-Rodríguez, R., Ballesteros-Pomar, M. D., Calleja‐Fernández, A., de Francisco, T. G., González-Herráez, L., Calleja-Antolín, S., Cano‐Rodríguez, I., & Olcoz-Goñi, J. L. (2014) · PubMed · Cited by 23
Albani, A., Ferraù, F., Ciresi, A., Pivonello, R., Scaroni, C. M., Iacuaniello, D., Zilio, M., Guarnotta, V., Alibrandi, A., Messina, E., et al. (2018) · Endocrine · doi:10.1007/s12020-018-1524-5 · Cited by 23
“Since waist circumference alone is not able to differentiate between visceral and subcutaneous fat mass, recently VAI has been proposed as a marker of visceral fat dysfunction, which indirectly reflects cardiometabolic risk [14, 15].”
BackgroundSelf-citationAssociation of body composition indexes with cardio-metabolic risk factors
Czeczelewski, M., Czeczelewski, J., Czeczelewska, E., & Galczak-Kondraciuk, A. (2019) · Obesity Medicine · doi:10.1016/j.obmed.2019.100171 · Cited by 23
Kiyici, S., Koca, N., Sigirli, D., Aslan, B. B., Guclu, M., & Kisakol, G. (2020) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2019.0108 · Cited by 22
Liu, M., Wang, C., Liu, R., Wang, Y., & Wei, B. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02408-2 · Cited by 22
Arslan, S., Şahin, K., Dal, N., Atan, R. M., & Selçuk, K. T. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112243 · Cited by 22
Pan, Y., Du, B., Feng, L., & Bi, J. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01919-x · Cited by 22
Iossa, D., Vitrone, M., Gagliardi, M., Falco, E., Ragone, E., Zampino, R., & Durante‐Mangoni, E. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-669 · Cited by 22
Chen, I.-J., Hsu, L.-T., Lu, M., Chen, Y.-J., Tsou, M.-T., & Chen, J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.737586 · Cited by 22
Is the visceral adiposity index a potential indicator for the risk of kidney stones?
Hou, B., Shen, X., He, Q., Chen, Y., Xu, Y., Chen, M., Xi, J., & Hao, Z. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1065520 · Cited by 22
“Frontiers in Endocrinology 07 circumference, BMI, and blood lipids (26).”
BackgroundSu, M., Wei, H., Chen, L., Guan, Y., Dong, W., & Zhao, M. (2023) · Medical Science Monitor · doi:10.12659/msm.941394 · Cited by 22
Cicero, A. F. G., Fogacci, F., Giovannini, M., Rizzoli, E., Grandi, E., D’Addato, S., & Borghi, C. (2023) · Nutrients · doi:10.3390/nu15214555 · Cited by 22
“Finally, the visceral adiposity index (VAI) was calculated as follows [23]: (WC (cm)/(39.68 + (1.88 × BMI))) × (TG (mmol/L)/1.03) × (1.31/HDL-C (mmol/L)) for males; and (WC/(36.58 + (1.89 × BMI))) × (TG/0.81) × (1.52/HDL-C) for females.”
InfluentialNagao, H., Kashine, S., Nishizawa, H., Okada, T., Kimura, T., Hirata, A., Fukuda, S., Kozawa, J., Maeda, N., Kitamura, T., et al. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-88 · Cited by 22
Wander, P. L., Hayashi, T., Satō, K., Uehara, S., Hikita, Y., Leonetti, D. L., Kahn, S. E., Fujimoto, W. Y., & Boyko, E. J. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.09.004 · Cited by 22
Okosun, I. S., Okosun, B., Lyn, R., & Airhihenbuwa, C. O. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.11.012 · Cited by 22
Yang, S., Dai, H., Hu, W., Geng, S., Li, L., Li, X., Liu, H., Liu, D., Li, K., Yang, G., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3373 · Cited by 22
Ma, Z., Zhang, J., Kang, X., Xu, C., Sun, C., Tao, L., Zheng, D., Han, Y., Li, Q., Guo, X., et al. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.08.006 · Cited by 22
Chen, T., Wang, X., Wang, X., Chen, H., Xiao, H., Tang, H., Feng, L., Xiang, Z., Zou, H., & Shao, X. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s286565 · Cited by 22
Bermúdez, V., Salazar, J. J., Fuenmayor, J., Nava, M., Ortega, Á., Durán, P., Rojas, M., Áñez, R., Montenegro, A. M. R., Angarita, L., et al. (2021) · Journal of Obesity · doi:10.1155/2021/5514901 · Cited by 22
Shi, Y., Yu, C., Hu, L., Li, M., Zhou, W., Wang, T., Zhu, L., Bao, H., Li, P., & Cheng, X. (2022) · Biology of Sex Differences · doi:10.1186/s13293-022-00432-4 · Cited by 22
Sun, J., Meng, X., Huang, H., Jing, J., Pan, Y., Mei, L., Jin, A., Wang, Y., Wei, T., & Cai, X. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112115 · Cited by 22
Joshi, H., Shah, K. H., Patel, P., Prajapati, J., Parmar, M., Doshi, D., & Chaurushia, S. (2016) · QJM · doi:10.1093/qjmed/hcw056 · Cited by 22
Stelmach-Mardas, M., Warchol, W. J., Garczyk, A., Warchoł, E., Korczak, J., Litwiniuk, M. M., Brajer-Luftmann, B., & Mardas, M. (2024) · Nutrients · doi:10.3390/nu16050656 · Cited by 21
“The VATI parameter is recognized as an indicator for early cardiometabolic risk [40].”
BackgroundYang, T., Zhao, B., & Pei, D. (2021) · Journal of Diabetes Research · doi:10.1155/2021/6503339 · Cited by 21
Cardiometabolic indices predict hypogonadism in male patients with type 2 diabetes
Caretta, N., Facondo, P., Mereu, S., Delbarba, A., Crepaldi, M., Vedovato, M., Avogaro, A., & Ferlin, A. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01941-0 · Cited by 21
Peng, W., Han, M., & Xu, G. (2023) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2023.102306 · Cited by 21
“VAI has been proposed as a reliable marker of visceral adiposity dysfunction, showing a positive correlation with visceral adiposity tissue (Amato et al., 2010).”
BackgroundZhang, D., Huo, W., Chen, W., Li, X., Qin, P., Zhang, M., Li, J., Sun, X., Liu, Y., & Hu, D. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.05.001 · Cited by 21
Gateva, A., Assyov, Y. S., Karamfilova, V., & Kamenov, Z. A. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108766 · Cited by 21
Torun, C., Ankaralı, H. Ç., Caştur, L., Uzunlulu, M., Erbakan, A. N., Akbaş, M. M., Gündüz, N., Doğan, M. B., Bahadır, M. A., & Oğuz, A. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1411678 · Cited by 21
“The newly developed model ’ s predictive accuracy in estimating increased CT-VAT was compared with the below-de fi ned adiposity indices (14 – 19).”
BackgroundResultGurjar, S., Ramanarayana Bhat, A., Upadhya, R., & Shenoy, R. P. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-024-02396-3 · Cited by 21
Empagliflozin as a new management strategy on outcomes in patients with type 2 diabetes mellitus
Салухов, В. В., & Demidova, T. Y. (2016) · Diabetes Mellitus · doi:10.14341/dm8216 · Cited by 21
Tian, Y., Ma, N., Jia, X., & Lü, Q. (2019) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-019-00677-w · Cited by 21
Changes in Visceral and Subcutaneous Fat in Youth With Type 2 Diabetes in the TODAY Study
Dhaliwal, R., Shepherd, J., ghormli, L. K. E., Copeland, K. C., Geffner, M. E., HIGGINS, J. A., Levitsky, L. L., Nadeau, K. J., Weinstock, R. S., & White, N. H. (2019) · Diabetes Care · doi:10.2337/dc18-1935 · Cited by 21
Can High Visceral Adiposity Index Be a Risk Factor for Sexual Dysfunction in Sexually Active Men?
Bolat, M. S., Kocamanoğlu, F., Özbek, L. M., Büyükalpelli, R., & Aşçı, R. (2020) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2020.06.014 · Cited by 21
Palacios‐González, B., León‐Reyes, G., Rivera‐Paredez, B., Ibarra‐González, I., Vela-Amieva, M. B., Flóres, Y. N., Canizales‐Quinteros, S., Salmerón, J., & Velázquez‐Cruz, R. (2021) · Metabolites · doi:10.3390/metabo11090604 · Cited by 21
Bozorgmanesh, M., Arshi, B., Sheikholeslami, F. H., Azizi, F., & Hadaegh, F. (2014) · International Journal of Endocrinology · doi:10.1155/2014/282089 · Cited by 21
SUITABILITY OF VISCERAL ADIPOSITY INDEX AS A MARKER FOR CARDIOMETABOLIC RISKS IN JORDANIAN ADULTS.
Ahmad, M. N., & Haddad, F. (2015) · PubMed · doi:10.3305/nh.2015.32.6.9543 · Cited by 21
Association between obesity and femoral neck strength according to age, sex, and fat distribution
Kim, H., Lee, S. H., Kim, B., & Koh, J. (2017) · Osteoporosis International · doi:10.1007/s00198-017-4015-2 · Cited by 21
Chen, Y., Chen, Y., Wang, N., Chen, C., Nie, X., Li, Q., Han, B., & Lu, Y. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-122235 · Cited by 21
Mazidi, M., Vatanparast, H., Katsiki, N., & Banach, M. (2018) · Oncotarget · doi:10.18632/oncotarget.25168 · Cited by 21
“52/HDL), where both TGs and HDL levels are expressed in mmol/L [36].”
BackgroundTeng, M., Wu, S., Er, L., Hsu, L., Chou, H., & Ko, Y. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0383-9 · Cited by 21
de Medeiros, S. F., de Medeiros, M. A. S., Barbosa, B. B., & Yamamoto, M. M. W. (2020) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2020.0045 · Cited by 21
Horan, A. A., Albsoul-Younes, A. M., Kasabri, V. N., Suyagh, M. F., Halaseh, L., & Alalawi, S. (2019) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2018-0051 · Cited by 20
Gökcen, B. B., Akdevelıoğlu, Y., Canan, S., & Bozkurt, N. (2020) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-020-00980-x · Cited by 20
Son, D., Ha, H., Lee, H. S., Han, D., Choi, S., Chun, E. J., Han, H., Park, S. H., Sung, J., Jung, H. O., et al. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.02.032 · Cited by 20
“VAI was developed using data from 315 healthy Italian adults; it is a useful visceral adiposity marker for assessing cardiovascular disease risk [7].”
BackgroundMethodInfluentialBisphenol S Promotes the Formation of Visceral Fat in Mice
Zhang, W., Gao, Y., Chen, C., Li, A., Ma, X., Liang, Y., Yao, X., Song, M., & Jiang, G. (2021) · Environmental Science & Technology Letters · doi:10.1021/acs.estlett.1c00419 · Cited by 20
Vega‐Cárdenas, M., Terán-García, M., Morales, J. M. V., Padrón‐Salas, A., & Aradillas-García, C. (2022) · American Journal of Human Biology · doi:10.1002/ajhb.23818 · Cited by 20
“…anthropometric parameters such as WC, BMI, and WHtR, and could significantly improve the assessment of CVD risk associated with obesity (Amato et al., 2010; Jabłonowska-Lietz et al., 2017), and may be beneficial in clinical practice for the identification of cardio metabolic risk…”
BackgroundChung, T., Liu, Y., Wu, P.-Y., Huang, J., & Chen, S. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1094471 · Cited by 20
“VAI score was calculated as described previously (32) using the following sex-specific equations (with TG levels in mmol/l and HDL-cholesterol levels in mmol/l):”
MethodChen, Z.-H., Zhou, T., Bu, Y., & Yang, L. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01931-y · Cited by 20
Zeng, Z., Huang, K., Cen, Y., Jin, W., Shen, Y., Xiong, L., Mao, F., Guo, H. W., Luo, Y., & Luo, X. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1270239 · Cited by 20
Lin, M., Xie, Y., Hong, L., Wu, S., Deng, X., Chen, Y., & Tan, X. (2023) · Public Health · doi:10.1016/j.puhe.2023.11.012 · Cited by 20
Rasaei, N., Gholami, F., Samadi, M., Shiraseb, F., Khadem, A., Yekaninejad, M. S., Emamgholipour, S., & Mirzaei, K. (2024) · Scientific Reports · doi:10.1038/s41598-023-50162-9 · Cited by 20
Liu, W., Weng, S., Chen, Y., Cao, C., & Peng, D. (2024) · Aging Clinical and Experimental Research · doi:10.1007/s40520-023-02660-z · Cited by 20
Xu, C., Song, Z., Wang, J., & Li, C.-C. (2024) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2024.100323 · Cited by 20
“Visceral adiposity index (VAI) is a gender-specific marker that incorporates anthropometric data and lipid profiles to provide a reliable predictor of visceral adiposity dysfunction [18].”
Metabolism score for visceral fat (METS-VF): an innovative and powerful predictor of stroke
Tan, A., Yang, S., Pan, Y., & Lin, Q. (2024) · Archives of Medical Science · doi:10.5114/aoms/193709 · Cited by 20
Metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome women
de Medeiros, S. F., Ormond, C. M., de Medeiros, M. A. S., dos Santos, N. V., Banhara, C. R., & Yamamoto, M. M. W. (2017) · Endocrine Connections · doi:10.1530/ec-17-0151 · Cited by 20
Lee, H. J., Jo, H. N., Kim, Y., Kim, S. C., Joo, J. K., & Lee, K. S. (2018) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2018.0019 · Cited by 20
“4,10,12,15 In general, the use of FLI to predict metabolic syndrome was rather concentrated in patients with ongoing fatty liver disease, but several studies on Asian population shows the significantly effective use of FLI even in the population without fatty liver disease.”
InfluentialKaramfilova, V., Assyov, Y. S., Nedeva, I., Gateva, A., Ivanova, I. D., Cherkezov, N., Mateva, L., & Kamenov, Z. A. (2021) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2021.0086 · Cited by 20
Esmaeili, V., Zendehdel, M., Shahverdi, A., & علیزاده, د. ع. (2022) · Andrologia · doi:10.1111/and.14524 · Cited by 20
Effect of Olive Pomace Oil on Cardiovascular Health and Associated Pathologies
González-Rámila, S., Sarriá, B., Seguido, M. Á., García-Cordero, J., Bravo, L., & Mateos, R. (2022) · Nutrients · doi:10.3390/nu14193927 · Cited by 20
Sung, H. H., Park, C.-E., Gi, M. Y., Cha, J. A., Moon, A. E., Kang, J. K., Seong, J.-M., Lee, J. H., & Yoon, H. J. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej19-0517 · Cited by 20
Volumen de grasa visceral como indicador de obesidad en hombres adultos
Muñoz, A. I. G., Niño-Silva, L. A., González‐Ruíz, K., & Ramírez‐Vélez, R. (2016) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2015.12.009 · Cited by 20
Ferraù, F., Spagnolo, F., Cotta, O. R., Cannavò, L., Alibrandi, A., Russo, G. T., Aversa, T., Trimarchi, F., & Cannavò, S. (2016) · Endocrine · doi:10.1007/s12020-016-1196-y · Cited by 20
“The VAI has been recently proposed as a marker of ATD and of the related cardiometabolic risk [12].”
BackgroundInfluentialPatino-Alonso, M. C., Gómez‐Sánchez, M., Gómez‐Sánchez, L., Sánchez-Salgado, B., Rodríguez‐Sánchez, E., García‐Ortiz, L., & Gómez-Marcos, M. Á. (2022) · Mathematics · doi:10.3390/math10040616 · Cited by 19
Non-invasive assessment of metabolic dysfunction–associated fatty liver disease
Kumar, C. V. C., Skantha, R., & Chan, W. (2022) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188221139614 · Cited by 19
Li, Y., Yu, D., Yang, Y., Cheng, X., Piao, W., Guo, Q., Xu, X., Zhao, L., & Wang, Y. (2023) · Nutrients · doi:10.3390/nu15092146 · Cited by 19
Uric acid level in climacteric women and its association with clinical and metabolic parameters
Souza, L. A. C. E., D’Angelo, G. C. D. O., da Silva, G. N., & Lima, A. A. (2023) · Scientific Reports · doi:10.1038/s41598-023-35287-1 · Cited by 19
Liang, D., Liu, C., & Yang, M. (2023) · BMC Nephrology · doi:10.1186/s12882-023-03421-w · Cited by 19
Metadata
- Authors
- Amato, M. C., Giordano, C., Galia, M., Criscimanna, A., Vitabile, S., Midiri, M., Galluzzo, A., & for the AlkaMeSy Study Group
- Affiliations
- University of Palermo (IT)
- Corresponding author
- Galluzzo, Aldo
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-01-12
- Volume
- 33
- Issue
- 4
- Pages
- 920-922
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2845052
- OpenAlex
- W2125944762
- Cited by
- 1,751
- References
- 14
- Citations by year
- 2026: 157 · 2025: 293 · 2024: 211 · 2023: 184 · 2022: 198 · 2021: 157 · 2020: 121 · 2019: 106 · 2018: 66 · 2017: 52 · 2016: 56 · 2015: 43 · 2014: 46 · 2013: 28 · 2012: 17
- FWCI
- 14.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- visceral adiposity index, visceral fat, waist circumference, body mass index, triglycerides, HDL cholesterol, metabolic syndrome, cardiovascular risk, cerebrovascular risk, insulin sensitivity, cardiometabolic risk
- MeSH terms
- Adult, Aged, Aged, 80 and over, Cardiovascular Diseases, Female, Humans, Cholesterol, HDL, Male, Middle Aged, Risk Factors, Triglycerides, Body Mass Index, Logistic Models, Intra-Abdominal Fat, Waist Circumference, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.